Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07924865
NA

Effects Of Topical Clobetasol Versus Coconut Oil Cream In The Treatment Of Oral Lichen Planus

Sponsor: Imaduddin Wasif

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if coconut oil cream works to treat oral lichen planus (OLP) in adults. It will also compare its effects and safety with clobetasol, a commonly used treatment for OLP. The main questions it aims to answer are: * Does coconut oil cream reduce the size of oral lichen planus lesions? * Does it reduce burning or pain in the mouth? * What medical problems or side effects do participants have during treatment? Researchers will compare coconut oil cream with clobetasol ointment to see how well each treatment works for oral lichen planus. Participants will: * Be randomly assigned to receive coconut oil cream or clobetasol ointment. * Apply their assigned treatment twice a day for 14 weeks. * Visit the clinic regularly for checkups and assessment of their oral lesions. * Have the size of their lesions measured and their burning sensation recorded during follow-up visits. * Be monitored for possible side effects such as mouth irritation, allergic reactions, oral fungal infection, or worsening of lesions. * If a participant receiving coconut cream does not improve or becomes worse within 2-4 weeks, they will be offered clobetasol as rescue treatment.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

116

Start Date

2026-06-15

Completion Date

2026-12-21

Last Updated

2026-11-12

Healthy Volunteers

No

Interventions

DRUG

Coconut Oil Cream group

This trial's coconut oil cream differs from prior OLP formulations (Mamadapur 2022, Alhat 2025, Pal 2026), which used coconut oil alone or with only one or two adjuncts. This is a compounded five-component preparation: Virgin Coconut Oil (50%) as the active base, beeswax (20%) as an occlusive vehicle, honey (15%) for antimicrobial/wound-healing support, aloe vera gel (10%) for mucosal soothing, and vitamin E oil (5%) as an antioxidant/penetration enhancer-offering a more comprehensive therapeutic profile than coconut oil alone. It will be prepared via standardized double-boiler compounding under supervisor oversight to reduce batch variability. The study also includes a pre-defined rescue protocol, transitioning non-responders (2-4 weeks) to clobetasol, and uses mobile photography with Adobe Photoshop for reproducible quantitative lesion measurement, unlike caliper- or visual-based methods elsewhere. Finally, this is the first such trial in a Pakistani population, where reticular OLP p

DRUG

Topical Clobetasol propionate 0.05%ointment

This trial's clobetasol arm (topical Clobetasol propionate 0.05% ointment) serves as the active comparator, distinguished from prior coconut-vs-steroid trials in several ways. Unlike Alhat et al. (2025), which compared coconut oil against triamcinolone acetonide, this trial uses clobetasol-as did Mamadapur (2022) and Pal (2026)-but applies an identical technique across both arms (mucosal drying, twice-daily application, 30-min post-application restriction), isolating drug effect from procedural variation. Treatment runs 14 weeks with structured follow-ups at weeks 2, 4, 8, 12, and 14-longer and more closely monitored than some prior designs. Outcomes are assessed by an independent blinded evaluator using standardized photography (Adobe Photoshop measurement) and the Numeric Pain Rating Scale, applied identically to both arms. Uniquely, this arm also serves as rescue therapy for non-responding coconut-group patients at 2-4 weeks-a dual comparator/rescue role absent from prior fixed-arm

Locations (1)

Abbasi Shaheed Hospital Karachi

Karachi, Sindh, Pakistan